Moreover, intra-TG injection of the T-type antagonist TTA-P2, systemic administration of Z944, or silencing of Cav3.2 was shown to produce significant analgesia in rodent models of trigeminal neuralgia [82, 83]. This evidence concerns the gene CACNA1H and trigeminal nerve disorder.